Nouvelle déclaration d'incident
No de la demande: 2013-1301
Numéro de référence du titulaire d'homologation: SC1009063
Nom du titulaire (nom légal complet, aucune abbréviation): Dow AgroSciences Canada Inc.
Adresse: 450-1st Street SW, Suite 2100
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2P 5H1
Incident chez l'humain
Pays: CANADA
État: ALBERTA
Inconnu
ARLA No d'homologation 28804 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Frontline XL Herbicide
Inconnu
Inconnu
Professionnel de la santé
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Inconnu
Non
Non professionnel
Aucun
Inconnu
Unknown / Inconnu
Unknown / Inconnu
July 17, 2012 Physician calling regarding a patient she has not yet seen or evaluated and was told that the patient has worked with this herbicide product in the past and has an issue with worsening peripheral neuropathy. It is unclear if the patient already had a history of peripheral neuropathy prior to his use of Frontline XL and that he is alleging a worsening of the neuropathy. The details of his usage of the product are not known. The physician wants to know the active ingredient in product and is concerned that the product may contain an organophosphate so would like to rule this out. The product Ingredients were discussed. The physician was informed that the herbicide does not contain an organophosphate.
Modérée
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. The product use history is extremely vague and lacks any description of a known or defined point of direct exposure to this product. Also, the reporting physician had not actually seen or examined the patient therefore the information provided is based on a vague recounting of events by the patient. Even had casual or incidental contact occurred during the normal use of this herbicide, neuropathy would not be an expected outcome. When considering the body of regulatory data and post-marketing data as well as the weight of scientific peer reviewed evidence on the ingredients used in this product a causal relationship appears to be scientifically implausible.